Aquisição do Medicamento Brolucizumab [120 MG/ML; SOL INJ; SERINGA] Para a ULSCB

ID 11096140 · Portal BASE
Price
Base Price
€15,971 .00
Effective Price
€15,971 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33690000
Location
Portugal
Bidder Count
1
Winner
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
Company
Competition
1 bidder recorded
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
Dates
Publication
19 Dec 2024
Celebration
06 Dec 2024
Contracting Entity
Unidade Local de Saúde de Castelo Branco, E. P. E.
NIF 509309844
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
19 Dec 2024
Signing Date
06 Dec 2024
Days Late
13
Rule
A2/A3 late publication: 13 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17